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Abstract
Background Since health-related quality of life (HRQL)
measures are numerous, comparisons have been suggested.
Aim To compare three HRQL measures: SF6D, HUI3 and
EQ5D.
Methods Three questionnaires (SF36, HUI3, EQ5D) were
administeredto1,011patientsattending16generalpractices
intwoItaliancities.Informationaboutpatients’gender,age,
education, marital status, smoking, body mass index (BMI)
andchronicdiseases(hypertension,diabetes,cardiovascular
and musculoskeletal diseases) were also collected. Ques-
tionnaires scores were calculated using the appropriate
algorithms; in particular SF6D scores were obtained from
SF36 items. Agreement and correlation between question-
naires scores were investigated using Bland and Altman
method and Spearman coefﬁcient. The inﬂuence of socio-
demographic and morbidity indicators on scores was ana-
lysed using the nonparametric quantile regression.
Results The Spearman coefﬁcient was about 0.6 for all
questionnaires. The 95% limits of agreement of the scores
were approximately from -0.5 to 0.3 except for SF6D and
EQ5D when they were from -0.4 to 0.2. The measures
were inﬂuenced by socio-demographic and clinical vari-
ables in a similar way, especially SF6D (the index obtained
from SF36) and EQ5D, which appeared to be inﬂuenced
by the same pattern of factors, including gender, chronic
diseases, smoking and BMI.
Conclusions Overall, the agreement between question-
naires scores was quite low, whilst the correlation level was
good. Questionnaire scores were inﬂuenced by socio-
demographic and clinical variables in a similar way,
especially SF6D and EQ5D. Therefore, the descriptive
capacity of SF6D and EQ5D was found to be similar.
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Abbreviations
BMI Body mass index
CI Conﬁdence interval
EQ5D Euroqol 5 Dimensions
GP General practitioner
HRQL Health-related quality of life
HUI3 Health Utility Index 3
QALY Quality adjusted life year
SD Standard deviation
SF36 Short Form 36
SF6D Short Form 6 Dimensions
Background
Health-related quality of life (HRQL) has become impor-
tant in ﬁelds such as health policy, clinical practice and
health outcome evaluation [1–6]. The use of outcome
models combining HRQL with morbidity or mortality is
increasing. This has led to the development of a series of
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cators, such as QALY [7–9]. HRQL preference/utility-
based measures are also increasingly used to obtain
QALYs [10, 11].
Since there are many preference/utility-based instru-
ments, there is a general demand for head-to-head
comparison studies between different scores [12]. Many of
the studies carried out have focussed on the SF6D, a
new tool representing the link between psychometric and
preference/utility-based measures. Most investigations
comparing SF6D with other widely used measures (e.g.,
EQ5D or HUI) have obtained contradictory ﬁndings. In
fact, it has been argued that, since these measures have
different scoring functions and deﬁne a different number of
health levels, it is not clear if their results can be compared.
SF6D is more sensitive than EQ5D and HUI3 in healthy
people, and in detecting small health changes, especially at
the top of the scale [11–14]. SF6D also shows a more
continuous and normal value distribution than EQ5D and
HUI3, which often have very skewed distributions or dis-
tributions clustered around a few values. Indeed, EQ5D
tends to suffer from clustering and ceiling effect in patients
with middle-severity health status [15]. On the other hand,
SF6D produces higher values than EQ5D or HUI3 at the
lower end of the scale. Thus, SF6D is likely to overestimate
the values of very impaired health status [16–22]. Since a
recent article [23] reported evidence that SF6D can
describe poor health status, it is not yet clear whether SF6D
has greater sensitivity and accuracy in the description of
health and advantages compared with other widely used,
shorter measures, such as EQ5D [20, 24].
EQ5D and HUI3 have only been compared in a limited
number of studies. Findings suggest that they give similar
results, though HUI3 discriminates better between lower
levels of impairment [11, 20, 25, 26].
Although a certain degree of correlation has been found
between these measures, which seem to assess a similar
essential construct, it is still not clear whether different
measures give similar results for HRQL. These previous
studies underlined that it is difﬁcult to establish whether
one tool is better than another because all have strengths
and weaknesses. However, the need for a standard measure
is increasingly felt because it has been seen that QALYs
calculated with different tools give different results [11, 16,
19]. Further research is also necessary because many of the
studies carried out so far suffered from limitations, such as
small sample sizes [16, 17, 21], or poor generalisation
because of focussing on a single population of patients with
a very speciﬁc disease [18–20, 22, 26]. Many of these
studies [13, 17, 18] only compared two tools, while a
broader examination of several different measures could be
useful. Finally, few studies have investigated the inﬂu-
ence of socio-demographic or morbidity factors on the
performances of different measures [27]. This aspect could
be important for two reasons: it could affect the compa-
rability of tools, and it could highlight which tools are most
sensitive for distinguishing health differences between
populations or groups within populations.
The aim of this study was to compare three distinct
HRQL measures, SF6D, HUI3 and EQ5D, in a population
not affected by speciﬁc diseases, speciﬁcally:
(1) formal agreement and correlation between measures;
(2) similarities and differences in the way measures are
independently related to a range of self-reported
socio-demographic and morbidity measures.
Methods
Study sample
Cross-sectional data were collected on a sample of patients
attending general practices in two Italian cities (Turin and
Siena) from May 2003 to April 2004. Turin is a big
industrial city (population 1,000,000), whereas Siena is a
town (population 50,000) with little industry. They were
chosen because a further aim of our study, not described in
this paper, was to describe the HRQL of GP patients in
different environments for local health policy purposes. All
patients attending the general practices during the study
period were eligible. The GPs were recruited with the
collaboration of the Primary Health Care Unit of the Local
Health Authority 2, ASL TO 1 of Turin and the Siena
division of the Italian Federation of General Practitioners
(Federazione Italiana Medici di Medicina Generale). Seven
GPs in Turin and nine in Siena agreed to participate. In the
end, 467 patients were enrolled in Turin and 544 in Siena,
making a total of 1,011 patients. There were no stated
patient exclusion criteria, but children (\16 years old) and
severely ill (hospitalised or bed ridden) patients were not
recruited due to the type of patients attending the GPs.
Study procedures
The GPs were recruited, and the licenses to use the ques-
tionnaires and the algorithms for calculating the scores
were acquired. HRQL data were collected using the Italian
version of the three questionnaires: SF36, HUI3 and EQ5D.
They were administered sequentially to the patients at the
general practices. The patients were informed about the
study by the GPs and were asked to participate. Written
informed consent was obtained from all who accepted.
Refusals were not recorded. The following information was
also obtained from each patient: date of birth, education,
marital status (married, not married, divorced/widowed),
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123smoking status (non-smoker, current smoker, ex-smoker),
height and weight to calculate BMI, and any history of
hypertension, cardiovascular diseases, diabetes or muscu-
loskeletal disorders (morbidity indicators were chosen
according to the advice of the GPs who indicated their
patients’ main complaints).
SF6D score was estimated from the SF36 questionnaire
using the established algorithm. EQ5D score was calcu-
lated using United Kingdom (UK) preference weights
[28] because Italian ones were not available. Patients
were divided into 10-year age groups, except for the
youngest and oldest (\30, 30–39, 40–49, 50–59, 60–69,
70?). Years of education were classiﬁed according to the
Italian school system. BMI was divided according to US
Centers for Disease Control & Prevention guidelines
(BMI C 25 = overweight) [29].
HUI3
HUI3 is a preference/utility-based measure that describes
eight attributes, ‘‘vision’’, ‘‘hearing’’, ‘‘speech’’, ‘‘ambula-
tion’’, ‘‘dexterity’’, ‘‘emotion’’, ‘‘cognition’’ and ‘‘pain’’,
and is able to identify 972,000 health states. The HUI
system is based on a ‘‘within the skin’’ approach to health
status assessment that concentrates on physical and emo-
tional aspects, ignoring social ones. The score ranges from
0 (death) to 1 (full health), but can also take negative
values that indicate states worse than death [30–34].
EQ5D
Euroqol5D is a preference/utility-based measure. The score
ranges from 0 (death) to 1 (full health), but may take
negative values. It describes ﬁve dimensions: ‘‘mobility’’,
‘‘self-care’’, ‘‘usual activities’’, ‘‘pain/discomfort’’ and
‘‘anxiety/depression’’, and identiﬁes 243 health states
[28, 35–37].
SF36
SF36 is a psychometric measure that produces a proﬁle
with eight dimensions: ‘‘physical functioning’’, ‘‘role lim-
itations due to physical problems’’ and ‘‘role limitations
due to emotional problems’’, ‘‘pain’’, ‘‘general health’’,
‘‘vitality’’, ‘‘social functioning’’ and ‘‘mental health’’ [38].
The eight dimensions can take values from 0 (worst health)
to 100 (best health) [39].
SF6D
SF6D is a preference/utility-based measure created to
obtain a score from the SF36. The eight dimensions of
SF36 were reduced to six SF6D dimensions: ‘‘physical
functioning’’, ‘‘role limitation’’, ‘‘social functioning’’,
‘‘pain’’, ‘‘mental health’’ and ‘‘vitality’’. The SF6D iden-
tiﬁes 18,000 health states. The score, which ranges from 0
(death) to 1 (full health), can be calculated from the SF36 if
the ten items used to identify the six dimensions of SF6D
are completed [16, 40, 41].
Data analysis
The analysis was carried out using Stata 8.1. The ques-
tionnaire score distributions were analysed. Correlation
was investigated using the Spearman coefﬁcient. Agree-
ment between scores was investigated using the Bland and
Altman [42] method.
Finally, how the questionnaire scores were inﬂuenced by
socio-demographic and morbidity indicators was studied
by univariate and multivariate analysis, using the non-
parametric quantile (Least Absolute Value) regression.
Missing values were excluded because they represented
only a small percentage of the data (6% for BMI and 3%
for chronic diseases) and because the groups of respondents
and non-respondents were similar in socio-demographic
and morbidity characteristics. Signiﬁcant (p\0.05) dif-
ferences were only found for marital status (the respondent
group contained a higher proportion of married persons).
Multivariate analysis was carried out ﬁtting a forward
step-up model. Only variables found to be associated with
questionnaire scores by the univariate analysis were
entered in the model. It was built up starting from the
socio-demographic indicators age and sex, which were
considered important factors. Then education and marital
status were entered followed by indicators related to life-
style, smoking status and BMI. Finally, the role of chronic
diseases was considered. Wald tests were carried out to
compare the new models with the previous ones.
Results
Basic characteristics of population surveyed
The mean age of patients was about 49 years (SD = 18).
There was a higher percentage of females (59%) than
males (41%). Sixty-one percent of the patients were mar-
ried. About half of the sample had never smoked. Current
and ex-smokers were more numerous among males (25 and
33%, respectively) than females (22 and 14%, respec-
tively). Mean BMI was 24 (SD = 3.9). Thirty-three
percent of the sample reported being overweight. Males
were more often overweight (44%) than females (25%).
Twenty-two percent of patients suffered from hyper-
tension, 28% from musculoskeletal diseases, 8% from
cardiovascular diseases and 5% from diabetes (Table 1).
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SF6D scores showed an almost normal distribution (Fig. 1),
whereas HUI3 and EQ5D scores were skewed to the left
(Figs. 2, 3). SF6D produced a narrower range of values:
while EQ5D and HUI3 showed negative scores, the mini-
mum SF6D score was 0.301 (SF6D mean 0.70, SD 0.11,
median 0.71, 25th percentile 0.62, 75th percentile 0.79,
maximum 0.94; EQ5D mean 0.80, SD 0.20, median 0.80,
25th percentile 0.72, 75th percentile 1, minimum -0.594,
maximum 1; HUI3 mean 0.76, SD 0.24, median 0.85, 25th
percentile 0.70, 75th percentile 0.91, minimum -0.371,
maximum 1). EQ5D showed a ceiling effect (31% of people
scored the highest value, compared to 6.5% for HUI3 and
0% for SF6D). The distribution of EQ5D clustered around a
few values with a big gap between 0.883 and 1.
Table 1 Characteristics of the study population (N = 1011)
%Males (N) %Females (N) %Overall (N)
Age (years)
\30 16.3 (68) 15.9 (94) 16.1 (162)
30–39 20.8 (87) 20.6 (122) 20.7 (209)
40–49 15.5 (65) 14.3 (85) 14.8 (150)
50–59 15.8 (66) 18.2 (108) 17.2 (174)
60–69 16.3 (68) 14.8 (88) 15.4 (156)
70? 15.3 (64) 16.2 (96) 15.8 (160)
Years of education
0–5 12.4 (52) 20.2 (120) 17.0 (172)
8 24.2 (101) 21.4 (127) 22.6 (228)
13 41.4 (173) 42.0 (249) 41.7 (422)
13? 22.0 (92) 16.4 (97) 18.7 (189)
Marital status
Married 61.2 (256) 61.4 (364) 61.3 (620)
Not married 34.5 (144) 27.8 (165) 30.6 (309)
Divorced/widowed 4.3 (18) 10.8 (64) 8.1 (82)
Smoking status
Never smoked 41.6 (174) 63.4 (376) 54.4 (550)
Current smoker 24.9 (104) 22.4 (133) 23.4 (237)
Ex-smoker 33.5 (140) 14.2 (84) 22.2 (224)
BMI
Not-overweight 48.1 (201) 69.7 (413) 60.7 (614)
Overweight 44.0 (184) 24.9 (148) 32.9 (332)
Not speciﬁed 7.9 (33) 5.4 (32) 6.4 (65)
Hypertension
Affected 21.5 (90) 21.6 (128) 21.6 (218)
Not speciﬁed 4.5 (19) 2.7 (16) 3.5 (35)
Cardiovascular diseases
Affected 8.4 (35) 7.2 (43) 7.7 (78)
Not speciﬁed 4.5 (19) 2.7 (16) 3.5 (35)
Diabetes
Affected 5.5 (23) 4.7 (28) 5.0 (51)
Not speciﬁed 4.5 (19) 2.7 (16) 3.5 (35)
Musculo-skeletal
Affected 18.9 (79) 33.9 (201) 27.7 (280)
Not speciﬁed 4.5 (19) 2.7 (16) 3.5 (35)
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123Correlation and agreement
The relationship between the questionnaire scores is
described in Figs. 4–6. SF6D and EQ5D showed the
highest level of association. This was conﬁrmed by
Spearman coefﬁcient, which was 0.59 for the association
between SF6D and EQ5D, 0.58 for SF6D and HUI3 and
0.57 for EQ5D and HUI3.
The best agreement was found between SF6D and
EQ5D (95% limits of agreement from -0.414 to 0.230).
The worst agreement was achieved by HUI3 and EQ5D
(95% limits of agreement from -0.463 to 0.387).
Multivariate analysis
Seven models were constructed for each questionnaire.
Table 2 shows the results of the ﬁrst model, which included
age and sex, and the ﬁnal model, where all the other
variables were entered. In the case of SF6D, after adjusting
for all the variables, females showed an average score
0.068 points lower than males (regression coefﬁcient =
-0.068, p\0.001). Ex-smokers showed a slightly lower
score than no-smokers (regression coefﬁcient =- 0.023,
p = 0.027). Overweight people had an average score 0.018
points lower than people of normal weight (regression
coefﬁcient =- 0.018, p = 0.020). Hypertension, cardio-
vascular diseases and musculoskeletal diseases show an
effect on the scores (respectively: regression coefﬁ-
cient =- 0.036, p = 0.001; regression coefﬁcient =
-0.035, p = 0.029; regression coefﬁcient =- 0.054,
p\0.001). Age, education and marital status did not
inﬂuence scores.
In the case of EQ5D, females showed an average score
0.085 points lower than males (regression coefﬁcient =
-0.085, p\0.001). People in the age group 60-69 showed
an average score 0.058 points (p = 0.028) lower than
people in the youngest group. Married people had an
average score higher than not married people (regression
coefﬁcient = 0.032, p = 0.056). Overweight people had
an average score 0.027 points lower than people of normal
weight (regression coefﬁcient =- 0.027, p = 0.028).
Hypertension and musculoskeletal diseases show an effect
on the scores (respectively: regression coefﬁcient =
-0.027, p = 0.065; regression coefﬁcient =- 0.071,
p\0.001). EQ5D scores were also inﬂuenced by smoking
status: current smokers had a score 0.035 points lower than
no smokers (regression coefﬁcient =- 0.035, p = 0.010).
In the case of HUI3, there were no signiﬁcant gender
differences in score values (females, regression coefﬁ-
cient =- 0.012, p = 0.303). The score increased with
higher education levels. Hypertension, cardiovascular dis-
eases and musculoskeletal diseases showed an effect on
the scores (respectively: regression coefﬁcient =- 0.037,
p = 0.014; regression coefﬁcient =- 0.055, p = 0.013;
regression coefﬁcient =- 0.081, p\0.001).
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123Discussion and conclusions
This study compared three widely used HRQL measures
and tried to clarify if they measure HRQL in a similar way.
The three measures showed different score ranges and
distributions, but EQ5D and HUI3 were more similar to
each other in distribution, mean, median, maximum and
minimum score than to SF6D. SF6D scores appeared to
have a more normal distribution and covered a narrower
range of values. EQ5D showed a ceiling effect with 31% of
people scoring the highest value. As highlighted by studies
with similar results, EQ5D seems to fail to describe mild-
severity health levels [16, 27].
In fact, with only three levels for each dimension, EQ5D
does not grade between fair and good health. However,
SF6D produced higher values for health conditions at the
lower end of the scale. The lowest SF6D score obtained in
this study was 0.301, while EQ5D and HUI3 produced
negative values. Other studies with similar results [11, 13,
21] interpreted this performance as a poor ability of SF6D
to distinguish severely impaired status. Overall, these
ﬁndings seem to conﬁrm those of other studies: SF6D
produced higher values at the lower end of the scale and
EQ5D at the upper end.
Differences between the questionnaires were also out-
lined by agreement between scores in the low range. The
95% limits of agreement were quite large, ranging
approximately from -0.5 to 0.3, which, on a score scale
from 0 to 1, is an important discrepancy. The best agree-
ment was achieved by SF6D and EQ5D and the worst by
EQ5D and HUI3. These results were probably due both to
construct and statistical issues. Regarding the construct
issue, HUI3 describes eight dimensions of health, six of
which are related to particular aspects (such as vision or
hearing), all focussed on the physical area of health. Only
two scales are related to emotional and mental health, and
none to social aspects of health. In fact, HUI3 is based on a
‘‘within the skin’’ approach to health status assessment that
concentrates on physical and emotional areas and elimi-
nates the social one because it is ‘‘outside the skin’’ [31–34].
On the contrary, SF6D and EQ5D not only describe phys-
ical and emotional dimensions of health, but also the social
one. These different constructs could explain the worse
agreement between HUI3 and the other measures. Regard-
ing the statistical issue, the particularly poor agreement
between HUI3 and EQ5D could be due to the skewed dis-
tributions of their scores. They both showed a ceiling effect,
but, in the case of EQ5D, there is also major clustering of
scores around a few values, which decreases the heteroge-
neity of the sample and hence the level of agreement whose
statistics rely upon variance. Moreover, the extreme score
values can lead to occurrence of outliers in the differences
distribution and therefore widen the limits of agreement.
However, the scores showed a good correlation. A
Spearman coefﬁcient of 0.6 is described as very high [43].
In our study, the Spearman coefﬁcient was around 0.6 for
all questionnaires, indicating a good level of correlation,
especially between SF6D and EQ5D. This level of corre-
lation was similar, but to some extent inferior to those
found in other studies [18, 20].
These ﬁndings highlighted that the results of HRQL
measures may be inﬂuenced by their frameworks and the
different methods used to calculate the scores. For exam-
ple, SF6D could overestimate the health status of persons
with severe illness and could be more suitable for surveys
on the general population or people with a fair to good
health status. However, EQ5D seems to overestimate
middle-severity health status and could therefore be less
suitable for describing the health status of the general
population and more useful for patients with invalidating
disease. Moreover, the three questionnaires are not inter-
changeable, and their results cannot be compared because
their results show poor agreement, especially between
HUI3 and EQ5D. This aspect could be a major issue in
comparisons among populations because health status
measured with different questionnaires is unlikely to be
comparable.
Considering the above, it comes as a surprise to discover
that the three measures had similar performance, especially
SF6D and EQ5D, in relation to socio-demographic and
clinical variables. In fact, this study highlighted that SF6D
and EQ5D scores are inﬂuenced by the same pattern of
factors. Multivariate analysis showed scores of the two
questionnaires were inﬂuenced, in particular, by gender,
with females showing poorer health than males, and by
chronic diseases, especially musculoskeletal. HRQL seems
to be inﬂuenced by the impact that diseases have on daily
life rather than by the severity or possible complications of
a disease. In fact, musculoskeletal diseases, usually painful
and debilitating, inﬂuence HRQL more than hypertension
or cardiovascular diseases. The two questionnaires show a
gender difference in health, though both are also inﬂuenced
by factors related to lifestyle, such as smoking and BMI.
HUI3, on the contrary, had slightly different perfor-
mance. It seemed to be inﬂuenced by educational level and
especially hypertension, cardiovascular and musculoskel-
etal diseases. However, HUI3 did not reveal health
differences between males and females and did not seem to
be inﬂuenced by factors related to lifestyle. This different
performance could be related, as mentioned above, to the
approach of the questionnaire, which focusses on physical
and emotional aspects and excludes social ones.
These results give rise to some considerations. First, the
scores of all questionnaires were inﬂuenced by musculo-
skeletal diseases, which are conditions characterised by
physical pain, difﬁculty of movements, immobility and,
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daily activities, and which, therefore, could have an effect
also on vitality and social life. Therefore, HRQL seems to
be inﬂuenced more by painful, and consequently daily-
activities-limiting, conditions than by diseases that may be
more serious, but are often asymptomatic. This could be a
limit as well as a way to highlight different aspects of
health. In fact, HRQL measures may underestimate health
status for painful, but not fatal diseases, while overesti-
mating health status in the case of serious, but
asymptomatic diseases. HRQL measures may therefore
help detect health needs that would otherwise remain
concealed, but should probably be used to integrate other
health measures, such as mortality, which are more
objective, but more crude, or they could be ‘‘adjusted’’ for
morbidity conditions assessed by more objective methods
(such as morbidity indexes, which describe the severity of a
disease).
Secondly, none of the three questionnaires, with the
exception of EQ5D, seemed to be inﬂuenced by age, after
adjusting for the other variables. This suggests that most of
the decrease in HRQL in old age is due to factors other
than age itself, such as diseases or other conditions like
loneliness, which are more frequent in the elderly.
Thirdly, SF6D and EQ5D show a similar capacity of
discrimination, while HUI3 seems to be less able to dis-
tinguish different categories of people. In particular, EQ5D
seems to be the only one to detect some health differences
between age groups and among smokers and non-smokers,
whilst SF6D identiﬁes differences between non-smokers
and ex-smokers. These results should be considered when
choosing a measure. Although the questionnaires have
diverse frameworks and their crude scores may be different
and difﬁcult to compare, they appeared to be inﬂuenced by
socio-demographic and morbidity variables in a similar
way, especially EQ5D and SF6D. This shifts emphasis
from the structural and construct similarities of different
instruments to the behaviour that they reveal when applied
in the ﬁeld. The study endeavoured to examine the per-
formance of the three measures when used to describe
patients’ condition and their determinants instead of merely
comparing ranges or distributions of scores. The results
obtained could help in the choice of instrument, also con-
sidering that this study did not focus on a group of patients
with a speciﬁc disease in order that the results are more
generalisable.
The present study shows some limitations: (1) all the
information about morbidity indicators is self-reported by
patients so they could be misclassiﬁed; (2) participation
was voluntary so there could be selection bias; (3) refusals
were not recorded so it was impossible to assess whether
people who refused to answer the questionnaires differed
from people who agreed. However, for the aim of the
study, these possible sources of error should not be of great
concern, because the biases would involve all three
instruments in the same way, and comparison would not be
altered. However, these possible sources of error could
affect the ability of the study to generalise the ﬁndings.
Another problem could be the order in which the ques-
tionnaires were administrated. Since they were always
administered in the same order, the last one could have
suffered from loss of accuracy. However, EQ5D, the last
one allocated to patients, is the shortest and easiest, so its
impletion was as good as for the other two.
In conclusion, our results show that EQ5D and HUI3
were closer to one another in many ways (score distribu-
tion, mean, median, minimum and maximum), but SF6D
and EQ5D scores were more similar in the way they were
inﬂuenced by socio-demographic and morbidity indicators.
In some cases, such as for smoking and age, EQ5D had
better discrimination capacity. It is difﬁcult to determine
which is the best instrument, but, apart from a descriptive
capacity similar or better than the other instruments, EQ5D
seems to have the advantage of being easier to answer.
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